Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02366949
Title Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer

Advanced Solid Tumor

triple-receptor negative breast cancer


BAY1217389 + Paclitaxel


Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Santa Monica California 90403 United States Details
Denver Colorado 80262 United States Details
New Haven Connecticut 06520 United States Details
Hackensack New Jersey 07601-1991 United States Details
Houston Texas 77030 United States Details
San Antonio Texas 78229-3307 United States Details
Rotterdam 3075 EA Netherlands Details
*Shaded cells indicate that there was no data available from for the field